LB&I Tier II Issue: Upfront Fees, Milestone Payments & Royalties in Biotech & Pharmaceutical Industries

Corporations | International Businesses | Partnerships | Small Business/Self-Employed

Businesses Topics

IRS Resources

LB&I Tier II Issue: Upfront Fees, Milestone Payments & Royalties in Biotech & Pharmaceutical Industries

Upfront Fees, Milestone Payments & Royalties in Biotech & Pharmaceutical Industries
Issue Owner: Lori Nichols, Director, Field Operations East, Retailers, Food, Pharmaceuticals, and Healthcare.

Directive - 05-07-2007
CIP - 10-18-2007
Directive #2 - 12-09-2010

Return to:
Issue Tiering - LB&I

Page Last Reviewed or Updated: February 07, 2012